Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs

BACKGROUND: Higher income population tend to prefer brand-name to generic drugs, which may cause disparity in access to brand-name drugs among income groups. A potential policy that can resolve such disparity is imposing a greater co-payment rate on high-income enrollees. However, the effects of suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Yuki, Hara, Konan, Yoo, Byung-Kwang, Tomio, Jun, Kobayashi, Yasuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824135/
https://www.ncbi.nlm.nih.gov/pubmed/31675967
http://dx.doi.org/10.1186/s12913-019-4598-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824135/
https://www.ncbi.nlm.nih.gov/pubmed/31675967
http://dx.doi.org/10.1186/s12913-019-4598-8

Ejemplares similares